Implantable magnetically-actuated capsule for on-demand delivery
Ying Zheng,Guizhou Zheng,Yuan Yuan Li,Xia Gong,Zhipeng Chen,Linyu Zhu,Yunsheng Xu,Xi Xie,Shuo Wu,Lelun Jiang
DOI: https://doi.org/10.1016/j.jconrel.2023.11.009
2023-01-01
Abstract:Many implantable drug delivery systems (IDDS) have been developed for long-term, pulsatile drug release. However, they are often limited by bulky size, complex electronic components, unpredictable drug delivery, as well as the need for battery replacement and consequent replacement surgery. Here, we develop an implantable magnetically-actuated capsule (IMAC) and its portable magnetic actuator (MA) for on-demand and robust drug delivery in a tether-free and battery-free manner. IMAC utilizes the bistable mechanism of two magnetic balls inside IMAC to trigger drug delivery under a strong magnetic field (vertical bar B-a vertical bar > 90 mT), ensuring precise and reproducible drug delivery (9.9 +/- 0.17 mu g per actuation, maximum actuation number: 180) and excellent anti-magnetic capability (critical trigger field intensity:-90 mT). IMAC as a tetherless robot can navigate to and anchor at the lesion sites driven by a gradient magnetic field del B-g = 3 T/m, vertical bar B-g vertical bar < 60 mT), and on-demand release drug actuated by a uniform magnetic field (vertical bar B-a vertical bar =-100 mT) within the gastrointestinal tract. During a 15-day insulin administration in vivo, the diabetic rats treated with IMAC exhibited highly similar pharma-cokinetic and pharmacodynamic profiles to those administrated via subcutaneous injection, demonstrating its robust and on-demand drug release performance. Moreover, IMAC is biocompatible, batter-free, refillable, miniature (only Phi 6.3 x 12.3 mm(3)), and lightweight (just 0.8 g), making it an ideal alternative for precise implantable drug delivery and friendly patient-centered drug administration.